Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Association between an interleukin-13 promoter polymorphism and atopy.

T Hummelshoj1, U Bodtger, P Datta

  • 1University Hospital of Copenhagen, Copenhagen, Denmark. tinahummelshoj@hotmail.com

European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics
|December 4, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey.

BMC neurology·2021
Same author

The HLA-DP2 protein binds the immunodominant epitope from myelin basic protein, MBP85-99, with high affinity.

Tissue antigens·2011
Same author

Neonatal Immune Thrombocytopenia Due to Allo-or Autoantibodies: Clinical and Immunological Analysis of 83 Cases.

Platelets·2010
Same author

Nomenclature for factors of the HLA system, 2010.

Tissue antigens·2010
Same author

An update to HLA nomenclature, 2010.

Bone marrow transplantation·2010
Same author

Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis.

Genes and immunity·2009

The Interleukin-13 (IL-13) gene promoter polymorphism at -1024 is strongly associated with inhalation allergy and atopic dermatitis. This genetic marker provides a predisposition to these allergic conditions in Caucasian subjects.

Area of Science:

  • Immunogenetics
  • Allergology

Background:

  • Genetic factors, particularly Th2 cytokines like Interleukin-13 (IL-13), are implicated in allergic diseases.
  • The IL-13 gene, located on chromosome 5q31-33, has been linked to atopic conditions.
  • Previous studies reported conflicting positions for a promoter polymorphism in the IL-13 gene associated with allergic asthma.

Purpose of the Study:

  • To clarify the precise location of the IL-13 promoter polymorphism.
  • To investigate the association of this polymorphism with atopic conditions, including allergic asthma, inhalation allergy, atopic dermatitis, and multiple sclerosis (MS).

Main Methods:

  • Genotyping of the IL-13 promoter polymorphism at position -1024 relative to the ATG codon.
  • Case-control association studies in Caucasian subjects.

Related Experiment Videos

  • Meta-analysis combining data from three independent studies.

    • Main Results:

    • The IL-13 -1024TT genotype was confirmed to be associated with inhalation allergy (P = 2.4E-02).
    • Combined analysis of three studies revealed a significant association between the IL-13 -1024 marker and inhalation allergy (P = 1.09E-05).
    • A novel association was identified between the IL-13 -1024 marker and atopic dermatitis (P = 2.0E-02). No association was found with multiple sclerosis.

    Conclusions:

    • The IL-13 gene promoter polymorphism at -1024 is a significant genetic marker for predisposition to inhalation allergy.
    • This study provides the first evidence linking the IL-13 -1024 polymorphism to atopic dermatitis.
    • The findings highlight the role of IL-13 in the pathogenesis of allergic diseases.